Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)

Slides:

Advertisements

Similar presentations

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.

Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /

Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal.

Critical Reviews in Oncology / Hematology

Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma Q. Le, A.

Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without.

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature Omar Abdel-Rahman,

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial Susanne M.

Critical Reviews in Oncology / Hematology

Shanthi Marur, MD, Arlene A. Forastiere, MD Mayo Clinic Proceedings

Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma Alexey Surov, Hans Jonas Meyer, Matthias Gawlitza,

Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis Alexey Surov, Hans Jonas.

Alzheimer's disease drug development pipeline: 2018

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma M. Ashton, N. O'Rourke, N.

Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer Delmy Oliva, Mats Nilsson, Bengt-Åke Andersson,

Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report Beatriz E. Amendola, Naipy C. Perez,

In This Issue Cell Volume 158, Issue 5, (August 2014)

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians) Carsten Nieder, Thomas A.

Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,

Miles Basil, Anita Pudusseri, Robert Lowe

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy Antoine Schernberg, Pierre Blanchard, Cyrus.

Volume 26, Issue 2, Pages (February 2018)

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.

Kavitha K. Reddy Journal of Investigative Dermatology

Jojanneke M. Seinen, Maarten G

Volume 152, Issue 1, (January 2013)

Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy Sara Leibfarth, René M. Winter, Heidi Lyng, Daniel Zips, Daniela.

Clinical and Translational Radiation Oncology

Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer Kenneth Jensen, Maja Bendtsen Sharma, Simon Lenler-Eriksen, Per Friis, Anne.

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer Sweet Ping.

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung.

Volume 130, Issue 6, (September 2007)

Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated.

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy Cédric Chevalier,

Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx:

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le,

Jean-Emmanuel Bibault, Ingeborg Tinhofer

What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the.

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor.

Jean-Emmanuel Bibault, Pierfrancesco Franco, Gerben R

Volume 143, Issue 6, (December 2010)

Volume 17, Issue 2, Pages (February 1950)

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.

Renal Pyelocalyceal Squamous Cell Carcinoma

Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas Debra Nana Yeboa, James B. Yu,

Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,

Joaquim Bellmunt European Urology Supplements

Ending 40 years of silence: Rationale for a new staging system for soft tissue sarcoma of the head and neck Ezra Hahn, Shao Hui Huang, Ali Hosni, Albiruni.

Squamous Cell Carcinoma of the Tongue

Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists Jennifer Strijbos,

PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing J. Jiang, Y. Zhang, C. Jin, J.

3A.01 Efficacy of Programmatic Combined Stereotactic Ablative Radiotherapy and Anti- PD-1 Therapy in Advanced Lung Cancer: A Retrospective Analysis A.

Jan Roigas European Urology Supplements

Volume 163, Issue 4, (November 2015)

Volume 4, Issue 1, Pages 2-3 (February 2006)

Risk factors for head and neck squamous cell carcinomas amongst patients attending a tertiary care centre of Assam Bhupendra Narayan Mahanta, Bhabadev.

Simulation in Advanced Practice Nursing

Volume 163, Issue 2, (October 2015)

Volume 50, Issue 2, Pages iii-iv (April 2019)

Volume 134, Issue 6, (September 2008)

Clinical and Translational Radiation Oncology

In This Issue Cell Volume 145, Issue 3, (April 2011)

Volume 148, Issue 1, (January 2012)

Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy Mercy Ofuya, Lucy McParland, Louise Murray,

Presentation transcript:

Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) Pierluigi Bonomo, Isacco Desideri, Mauro Loi, Monica Mangoni, Mariangela Sottili, Livia Marrazzo, Cinzia Talamonti, Daniela Greto, Stefania Pallotta, Lorenzo Livi Clinical and Translational Radiation Oncology Volume 9, Pages 42-47 (February 2018) DOI: 10.1016/j.ctro.2018.01.005 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 Study schema. Clinical and Translational Radiation Oncology 2018 9, 42-47DOI: (10.1016/j.ctro.2018.01.005) Copyright © 2018 The Authors Terms and Conditions